We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+1.61%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$94B
AUM Growth
-$5.55B
(-5.6%)
Cap. Flow
-$6.11B
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
18.25%
Holding
5,056
New
758
Increased
1,544
Reduced
1,769
Closed
869
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.52B |
| 2 |
Broadcom
AVGO
|
+$409M |
| 3 |
ServiceNow
NOW
|
+$359M |
| 4 |
Tesla
TSLA
|
+$230M |
| 5 |
T-Mobile US
TMUS
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$328M |
| 2 |
Walmart Inc
WMT
|
+$253M |
| 3 |
Workday
WDAY
|
+$236M |
| 4 |
Intel
INTC
|
+$235M |
| 5 |
Eli Lilly
LLY
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.46% |
| 2 | Consumer Discretionary | 6.93% |
| 3 | Industrials | 5.09% |
| 4 | Financials | 5.05% |
| 5 | Healthcare | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Coherus Oncology
CHRS
$217M
| $132K | ﹤0.01% |
+92,756
| New | +$135K |
|
3977
Cartesian Therapeutics
RNAC
$232M
| $131K | ﹤0.01% |
+18,213
| New | +$147K |
|
|
CMPS
3978
Compass Pathways
CMPS
$1.52B
| $131K | ﹤0.01% |
+18,963
| New | +$116K |
|
3979
PUT
Rithm Capital
RITM
$5.09B
| $131K | ﹤0.01% |
12,000
+200
| +2% | +$2.21K |
|
|
INN
3980
Summit Hotel Properties
INN
$761M
| $130K | ﹤0.01% |
26,743
-9,749
| -27% | -$51K |
|
3981
Quad
QUAD
$430M
| $128K | ﹤0.01% |
20,472
-2,398
| -10% | -$14.1K |
|
3982
Passage Bio
PASG
$15.9M
| $127K | ﹤0.01% |
10,799
-12,701
| -54% | -$110K |
|
3983
Northern Technologies International Corp
NTIC
$76.4M
| $126K | ﹤0.01% |
16,129
-6,882
| -30% | -$52.9K |
|
3984
Altimmune
ALT
$539M
| $126K | ﹤0.01% |
34,949
-549,747
| -94% | -$2.4M |
|
3985
Vir Biotechnology
VIR
$1.47B
| $126K | ﹤0.01% |
20,867
-256,448
| -92% | -$1.53M |
|
3986
CALL
Pacific Biosciences
PACB
$422M
| $124K | ﹤0.01% |
66,400
-500
| -0.7% | -$961 |
|
3987
CALL
Hertz
HTZ
$572M
| $124K | ﹤0.01% |
24,100
-20,000
| -45% | -$109K |
|
3988
Fossil Group
FOSL
$239M
| $124K | ﹤0.01% |
+32,919
| New | +$92.9K |
|
|
EEX
3989
DELISTED
Emerald Holding
EEX
| $123K | ﹤0.01% |
27,427
-19,937
| -42% | -$85.8K |
|
|
NNDM
3990
Nano Dimension
NNDM
$309M
| $122K | ﹤0.01% |
79,418
+12,451
| +19% | +$21.1K |
|
3991
CALL
Under Armour Class C
UA
$2.92B
| $122K | ﹤0.01% |
+25,400
| New | +$113K |
|
3992
Cognyte Software
CGNT
$612M
| $122K | ﹤0.01% |
12,943
-39,237
| -75% | -$339K |
|
|
ODV
3993
DELISTED
Osisko Development Corp
ODV
| $121K | ﹤0.01% |
34,727
+17,868
| +106% | +$61.4K |
|
3994
Alector
ALEC
$164M
| $121K | ﹤0.01% |
+77,618
| New | +$138K |
|
3995
Pliant Therapeutics
PLRX
$67.5M
| $121K | ﹤0.01% |
99,018
+65,176
| +193% | +$97.9K |
|
3996
TriplePoint Venture Growth BDC
TPVG
$180M
| $121K | ﹤0.01% |
+18,428
| New | +$110K |
|
3997
Kimbell Royalty Partners
KRP
$1.47B
| $120K | ﹤0.01% |
+10,224
| New | +$131K |
|
3998
CALL
Intellia Therapeutics
NTLA
$1.5B
| $120K | ﹤0.01% |
+13,300
| New | +$183K |
|
3999
BCB Bancorp
BCBP
$176M
| $120K | ﹤0.01% |
+14,810
| New | +$119K |
|
4000
CALL
NextDecade
NEXT
$1.86B
| $119K | ﹤0.01% |
+22,600
| New | +$135K |
|
Similar funds
Squarepoint's Q4 2025 Portfolio in Review
As of Q4 2025, Squarepoint held 5,056 positions worth $94B, down 5.6% from $99.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Squarepoint withdrew a net $6.11B in Q4 2025, closing 869 positions and reducing 1,769 holdings. Its most notable exit was State Street Communication Services Select Sector SPDR ETF, an estimated $328M position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Squarepoint opened a new position in Medline Inc worth $79.8M.
- Squarepoint's largest Q4 2025 buy was Medline Inc: 1,900,000 shares worth $79.8M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $1.52B increase.
- Squarepoint's biggest Q4 2025 reduction was Walmart Inc, cutting an estimated $253M.
- Squarepoint fully exited State Street Communication Services Select Sector SPDR ETF in Q4 2025, selling an estimated $328M.
- Squarepoint's ten largest holdings make up 18% of its $94B portfolio in Q4 2025.
- Squarepoint opened 758 new positions and closed 869 in Q4 2025.
- Squarepoint's portfolio value fell 5.6% quarter-over-quarter to $94B.
Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.